Vanhove Geertrui 4
4 · Surrozen, Inc./DE · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Vanhove Geertrui
Chief Medical Officer
Transactions
- Award
Option Grant (right to buy)
2022-03-01$3.11/sh+125,000$388,750→ 125,000 totalExercise: $3.11From: 2022-02-01Exp: 2032-03-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2022, subject to the reporting person's continued employment through the applicable vesting date.